Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
According to the research report, the global market for Drug and Gene Delivery System should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
China Drug and Gene Delivery System market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States Drug and Gene Delivery System market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, Drug Delivery System segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Diabetes has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of Drug and Gene Delivery System include Pfizer, Johnson & Johnson, Novartis, Roche, Merck & Co., Sanofi, GlaxoSmithKline, AbbVie and AstraZeneca, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive study of the global market for Drug and Gene Delivery System. Report Highlights:
(1) Global Drug and Gene Delivery System market size (value), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global Drug and Gene Delivery System market competitive situation, revenue and market share, from 2018 to 2022.
(3) China Drug and Gene Delivery System market competitive situation, revenue and market share, from 2018 to 2022.
(4) Global Drug and Gene Delivery System segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Drug and Gene Delivery System segment by type and by application and regional segment by type and by application.
(6) Drug and Gene Delivery System industry supply chain, upstream, midstream and downstream analysis.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
Drug Delivery System
Gene Delivery System
Market segment by application, can be divided into
Diabetes
Central Nervous System
Infectious Disease
Oncology
Other
Market segment by players, this report covers
Pfizer
Johnson & Johnson
Novartis
Roche
Merck & Co.
Sanofi
GlaxoSmithKline
AbbVie
AstraZeneca
Bayer
Bristol-MyersSquibb
Celgene
Amgen
Biogen
Gilead Sciences
Illumina
Regeneron Pharmaceuticals
Vertex Pharmaceuticals
Moderna
CRISPR Therapeutics
1 Market Overview
1.1 Product Overview and Scope of Drug and Gene Delivery System
1.2 Global Drug and Gene Delivery System Market Size and Forecast
1.3 China Drug and Gene Delivery System Market Size and Forecast
1.4 China Market Percentage in Global
1.4.1 By Revenue, China Drug and Gene Delivery System Share in Global Market, 2018-2029
1.4.2 Drug and Gene Delivery System Market Size: China VS Global, 2018-2029
1.5 Drug and Gene Delivery System Market Dynamics
1.5.1 Drug and Gene Delivery System Market Drivers
1.5.2 Drug and Gene Delivery System Market Restraints
1.5.3 Drug and Gene Delivery System Industry Trends
1.5.4 Drug and Gene Delivery System Industry Policy
2 Global Competitive Situation by Company
2.1 Global Drug and Gene Delivery System Revenue by Company (2018-2023)
2.2 Global Drug and Gene Delivery System Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.3 Global Drug and Gene Delivery System Concentration Ratio
2.4 Global Drug and Gene Delivery System Mergers & Acquisitions, Expansion Plans
2.5 Global Drug and Gene Delivery System Manufacturers Product Type
3 China Competitive Situation by Company
3.1 China Drug and Gene Delivery System Revenue by Company (2018-2023)
3.2 China Drug and Gene Delivery System Drug and Gene Delivery System Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.3 China Drug and Gene Delivery System, Revenue Percentage of Local Players VS Foreign Manufacturers (2018-2023)
4 Industry Chain Analysis
4.1 Drug and Gene Delivery System Industry Chain
4.2 Drug and Gene Delivery System Upstream Analysis
4.3 Drug and Gene Delivery System Midstream Analysis
4.4 Drug and Gene Delivery System Downstream Analysis
5 Sights by Type
5.1 Drug and Gene Delivery System Classification
5.1.1 Drug Delivery System
5.1.2 Gene Delivery System
5.2 By Type, Global Drug and Gene Delivery System Market Size & CAGR, 2018 VS 2022 VS 2029
5.3 By Type, Global Drug and Gene Delivery System Revenue, 2018-2029
6 Sights by Application
6.1 Drug and Gene Delivery System Segment by Application
6.1.1 Diabetes
6.1.2 Central Nervous System
6.1.3 Infectious Disease
6.1.4 Oncology
6.1.5 Other
6.2 By Application, Global Drug and Gene Delivery System Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Application, Global Drug and Gene Delivery System Revenue, 2018-2029
7 Sales Sights by Region
7.1 By Region, Global Drug and Gene Delivery System Market Size, 2018 VS 2022 VS 2029
7.2 By Region, Global Drug and Gene Delivery System Market Size, 2018-2029
7.3 North America
7.3.1 North America Drug and Gene Delivery System Market Size & Forecasts, 2018-2029
7.3.2 By Country, North America Drug and Gene Delivery System Market Size Market Share
7.4 Europe
7.4.1 Europe Drug and Gene Delivery System Market Size & Forecasts, 2018-2029
7.4.2 By Country, Europe Drug and Gene Delivery System Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific Drug and Gene Delivery System Market Size & Forecasts, 2018-2029
7.5.2 By Country/Region, Asia Pacific Drug and Gene Delivery System Market Size Market Share
7.6 South America
7.6.1 South America Drug and Gene Delivery System Market Size & Forecasts, 2018-2029
7.6.2 By Country, South America Drug and Gene Delivery System Market Size Market Share
7.7 Middle East & Africa
8 Sights by Country Level
8.1 By Country, Global Drug and Gene Delivery System Market Size & CAGR,2018 VS 2022 VS 2029
8.2 By Country, Global Drug and Gene Delivery System Market Size, 2018-2029
8.3 U.S.
8.3.1 U.S. Drug and Gene Delivery System Market Size, 2018-2029
8.3.2 By Company, U.S. Drug and Gene Delivery System Revenue Market Share, 2018-2023
8.3.3 By Type, U.S. Drug and Gene Delivery System Revenue Market Share, 2022 VS 2029
8.3.4 By Application, U.S. Drug and Gene Delivery System Revenue Market Share, 2022 VS 2029
8.4 Europe
8.4.1 Europe Drug and Gene Delivery System Market Size, 2018-2029
8.4.2 By Company, Europe Drug and Gene Delivery System Revenue Market Share, 2018-2023
8.4.3 By Type, Europe Drug and Gene Delivery System Revenue Market Share, 2022 VS 2029
8.4.4 By Application, Europe Drug and Gene Delivery System Revenue Market Share, 2022 VS 2029
8.5 China
8.5.1 China Drug and Gene Delivery System Market Size, 2018-2029
8.5.2 By Company, China Drug and Gene Delivery System Revenue Market Share, 2018-2023
8.5.3 By Type, China Drug and Gene Delivery System Revenue Market Share, 2022 VS 2029
8.5.4 By Application, China Drug and Gene Delivery System Revenue Market Share, 2022 VS 2029
8.6 Japan
8.6.1 Japan Drug and Gene Delivery System Market Size, 2018-2029
8.6.2 By Company, Japan Drug and Gene Delivery System Revenue Market Share, 2018-2023
8.6.3 By Type, Japan Drug and Gene Delivery System Revenue Market Share, 2022 VS 2029
8.6.4 By Application, Japan Drug and Gene Delivery System Revenue Market Share, 2022 VS 2029
8.7 South Korea
8.7.1 South Korea Drug and Gene Delivery System Market Size, 2018-2029
8.7.2 By Company, South Korea Drug and Gene Delivery System Revenue Market Share, 2018-2023
8.7.3 By Type, South Korea Drug and Gene Delivery System Revenue Market Share, 2022 VS 2029
8.7.4 By Application, South Korea Drug and Gene Delivery System Revenue Market Share, 2022 VS 2029
8.8 Southeast Asia
8.8.1 Southeast Asia Drug and Gene Delivery System Market Size, 2018-2029
8.8.2 By Company, Southeast Asia Drug and Gene Delivery System Revenue Market Share, 2018-2023
8.8.3 By Type, Southeast Asia Drug and Gene Delivery System Revenue Market Share, 2022 VS 2029
8.8.4 By Application, Southeast Asia Drug and Gene Delivery System Revenue Market Share, 2022 VS 2029
8.9 India
8.9.1 India Drug and Gene Delivery System Market Size, 2018-2029
8.9.2 By Company, India Drug and Gene Delivery System Revenue Market Share, 2018-2023
8.9.3 By Type, India Drug and Gene Delivery System Revenue Market Share, 2022 VS 2029
8.9.4 By Application, India Drug and Gene Delivery System Revenue Market Share, 2022 VS 2029
8.10 Middle East & Asia
8.10.1 Middle East & Asia Drug and Gene Delivery System Market Size, 2018-2029
8.10.2 By Company, Middle East & Asia Drug and Gene Delivery System Revenue Market Share, 2018-2023
8.10.3 By Type, Middle East & Asia Drug and Gene Delivery System Revenue Market Share, 2022 VS 2029
8.10.4 By Application, Middle East & Asia Drug and Gene Delivery System Revenue Market Share, 2022 VS 2029
9 Global Manufacturers Profile
9.1 Pfizer
9.1.1 Pfizer Company Information, Head Office, Market Area and Industry Position
9.1.2 Pfizer Company Profile and Main Business
9.1.3 Pfizer Drug and Gene Delivery System Models, Specifications and Application
9.1.4 Pfizer Drug and Gene Delivery System Revenue and Gross Margin, 2018-2023
9.1.5 Pfizer Recent Developments
9.2 Johnson & Johnson
9.2.1 Johnson & Johnson Company Information, Head Office, Market Area and Industry Position
9.2.2 Johnson & Johnson Company Profile and Main Business
9.2.3 Johnson & Johnson Drug and Gene Delivery System Models, Specifications and Application
9.2.4 Johnson & Johnson Drug and Gene Delivery System Revenue and Gross Margin, 2018-2023
9.2.5 Johnson & Johnson Recent Developments
9.3 Novartis
9.3.1 Novartis Company Information, Head Office, Market Area and Industry Position
9.3.2 Novartis Company Profile and Main Business
9.3.3 Novartis Drug and Gene Delivery System Models, Specifications and Application
9.3.4 Novartis Drug and Gene Delivery System Revenue and Gross Margin, 2018-2023
9.3.5 Novartis Recent Developments
9.4 Roche
9.4.1 Roche Company Information, Head Office, Market Area and Industry Position
9.4.2 Roche Company Profile and Main Business
9.4.3 Roche Drug and Gene Delivery System Models, Specifications and Application
9.4.4 Roche Drug and Gene Delivery System Revenue and Gross Margin, 2018-2023
9.4.5 Roche Recent Developments
9.5 Merck & Co.
9.5.1 Merck & Co. Company Information, Head Office, Market Area and Industry Position
9.5.2 Merck & Co. Company Profile and Main Business
9.5.3 Merck & Co. Drug and Gene Delivery System Models, Specifications and Application
9.5.4 Merck & Co. Drug and Gene Delivery System Revenue and Gross Margin, 2018-2023
9.5.5 Merck & Co. Recent Developments
9.6 Sanofi
9.6.1 Sanofi Company Information, Head Office, Market Area and Industry Position
9.6.2 Sanofi Company Profile and Main Business
9.6.3 Sanofi Drug and Gene Delivery System Models, Specifications and Application
9.6.4 Sanofi Drug and Gene Delivery System Revenue and Gross Margin, 2018-2023
9.6.5 Sanofi Recent Developments
9.7 GlaxoSmithKline
9.7.1 GlaxoSmithKline Company Information, Head Office, Market Area and Industry Position
9.7.2 GlaxoSmithKline Company Profile and Main Business
9.7.3 GlaxoSmithKline Drug and Gene Delivery System Models, Specifications and Application
9.7.4 GlaxoSmithKline Drug and Gene Delivery System Revenue and Gross Margin, 2018-2023
9.7.5 GlaxoSmithKline Recent Developments
9.8 AbbVie
9.8.1 AbbVie Company Information, Head Office, Market Area and Industry Position
9.8.2 AbbVie Company Profile and Main Business
9.8.3 AbbVie Drug and Gene Delivery System Models, Specifications and Application
9.8.4 AbbVie Drug and Gene Delivery System Revenue and Gross Margin, 2018-2023
9.8.5 AbbVie Recent Developments
9.9 AstraZeneca
9.9.1 AstraZeneca Company Information, Head Office, Market Area and Industry Position
9.9.2 AstraZeneca Company Profile and Main Business
9.9.3 AstraZeneca Drug and Gene Delivery System Models, Specifications and Application
9.9.4 AstraZeneca Drug and Gene Delivery System Revenue and Gross Margin, 2018-2023
9.9.5 AstraZeneca Recent Developments
9.10 Bayer
9.10.1 Bayer Company Information, Head Office, Market Area and Industry Position
9.10.2 Bayer Company Profile and Main Business
9.10.3 Bayer Drug and Gene Delivery System Models, Specifications and Application
9.10.4 Bayer Drug and Gene Delivery System Revenue and Gross Margin, 2018-2023
9.10.5 Bayer Recent Developments
9.11 Bristol-MyersSquibb
9.11.1 Bristol-MyersSquibb Company Information, Head Office, Market Area and Industry Position
9.11.2 Bristol-MyersSquibb Company Profile and Main Business
9.11.3 Bristol-MyersSquibb Drug and Gene Delivery System Models, Specifications and Application
9.11.4 Bristol-MyersSquibb Drug and Gene Delivery System Revenue and Gross Margin, 2018-2023
9.11.5 Bristol-MyersSquibb Recent Developments
9.12 Celgene
9.12.1 Celgene Company Information, Head Office, Market Area and Industry Position
9.12.2 Celgene Company Profile and Main Business
9.12.3 Celgene Drug and Gene Delivery System Models, Specifications and Application
9.12.4 Celgene Drug and Gene Delivery System Revenue and Gross Margin, 2018-2023
9.12.5 Celgene Recent Developments
9.13 Amgen
9.13.1 Amgen Company Information, Head Office, Market Area and Industry Position
9.13.2 Amgen Company Profile and Main Business
9.13.3 Amgen Drug and Gene Delivery System Models, Specifications and Application
9.13.4 Amgen Drug and Gene Delivery System Revenue and Gross Margin, 2018-2023
9.13.5 Amgen Recent Developments
9.14 Biogen
9.14.1 Biogen Company Information, Head Office, Market Area and Industry Position
9.14.2 Biogen Company Profile and Main Business
9.14.3 Biogen Drug and Gene Delivery System Models, Specifications and Application
9.14.4 Biogen Drug and Gene Delivery System Revenue and Gross Margin, 2018-2023
9.14.5 Biogen Recent Developments
9.15 Gilead Sciences
9.15.1 Gilead Sciences Company Information, Head Office, Market Area and Industry Position
9.15.2 Gilead Sciences Company Profile and Main Business
9.15.3 Gilead Sciences Drug and Gene Delivery System Models, Specifications and Application
9.15.4 Gilead Sciences Drug and Gene Delivery System Revenue and Gross Margin, 2018-2023
9.15.5 Gilead Sciences Recent Developments
9.16 Illumina
9.16.1 Illumina Company Information, Head Office, Market Area and Industry Position
9.16.2 Illumina Company Profile and Main Business
9.16.3 Illumina Drug and Gene Delivery System Models, Specifications and Application
9.16.4 Illumina Drug and Gene Delivery System Revenue and Gross Margin, 2018-2023
9.16.5 Illumina Recent Developments
9.17 Regeneron Pharmaceuticals
9.17.1 Regeneron Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
9.17.2 Regeneron Pharmaceuticals Company Profile and Main Business
9.17.3 Regeneron Pharmaceuticals Drug and Gene Delivery System Models, Specifications and Application
9.17.4 Regeneron Pharmaceuticals Drug and Gene Delivery System Revenue and Gross Margin, 2018-2023
9.17.5 Regeneron Pharmaceuticals Recent Developments
9.18 Vertex Pharmaceuticals
9.18.1 Vertex Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
9.18.2 Vertex Pharmaceuticals Company Profile and Main Business
9.18.3 Vertex Pharmaceuticals Drug and Gene Delivery System Models, Specifications and Application
9.18.4 Vertex Pharmaceuticals Drug and Gene Delivery System Revenue and Gross Margin, 2018-2023
9.18.5 Vertex Pharmaceuticals Recent Developments
9.19 Moderna
9.19.1 Moderna Company Information, Head Office, Market Area and Industry Position
9.19.2 Moderna Company Profile and Main Business
9.19.3 Moderna Drug and Gene Delivery System Models, Specifications and Application
9.19.4 Moderna Drug and Gene Delivery System Revenue and Gross Margin, 2018-2023
9.19.5 Moderna Recent Developments
9.20 CRISPR Therapeutics
9.20.1 CRISPR Therapeutics Company Information, Head Office, Market Area and Industry Position
9.20.2 CRISPR Therapeutics Company Profile and Main Business
9.20.3 CRISPR Therapeutics Drug and Gene Delivery System Models, Specifications and Application
9.20.4 CRISPR Therapeutics Drug and Gene Delivery System Revenue and Gross Margin, 2018-2023
9.20.5 CRISPR Therapeutics Recent Developments
10 Conclusion
11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer
Tables & Figures:
Table 1. Drug and Gene Delivery System Market Size & CAGR: China VS Global, (US$ Million), 2018-2029
Table 2. Drug and Gene Delivery System Market Restraints
Table 3. Drug and Gene Delivery System Market Trends
Table 4. Drug and Gene Delivery System Industry Policy
Table 5. Global Drug and Gene Delivery System Revenue by Company (2018-2023) & (US$ million)
Table 6. Global Drug and Gene Delivery System Revenue Market Share by Company (2018-2023)
Table 7. Global Drug and Gene Delivery System Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 8. Global Drug and Gene Delivery System Mergers & Acquisitions, Expansion Plans
Table 9. Global Drug and Gene Delivery System Manufacturers Product Type
Table 10. China Drug and Gene Delivery System Revenue by Company (2018-2023) & (US$ million)
Table 11. China Drug and Gene Delivery System Revenue Market Share by Company (2018-2023)
Table 12. Global Key Players of Drug and Gene Delivery System Upstream (Raw Materials)
Table 13. Global Drug and Gene Delivery System Typical Customers
Table 14. Drug and Gene Delivery System Typical Distributors
Table 15. By Type, Global Drug and Gene Delivery System Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 16. By Application, Global Drug and Gene Delivery System Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 17. By Region, Global Drug and Gene Delivery System Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 18. By Region, Global Drug and Gene Delivery System Revenue, 2018-2029, US$ Million
Table 19. By Country, Global Drug and Gene Delivery System Revenue & CAGR,2018 VS 2022 VS 2029, US$ Million
Table 20. By Country, Global Drug and Gene Delivery System Revenue, 2018-2029, US$ Million
Table 21. By Country, Global Drug and Gene Delivery System Revenue Market Share, 2018-2029
Table 22. Pfizer Company Information, Head Office, Market Area and Industry Position
Table 23. Pfizer Company Profile and Main Business
Table 24. Pfizer Drug and Gene Delivery System Models, Specifications and Application
Table 25. Pfizer Drug and Gene Delivery System Revenue and Gross Margin, 2018-2023
Table 26. Pfizer Recent Developments
Table 27. Johnson & Johnson Company Information, Head Office, Market Area and Industry Position
Table 28. Johnson & Johnson Company Profile and Main Business
Table 29. Johnson & Johnson Drug and Gene Delivery System Models, Specifications and Application
Table 30. Johnson & Johnson Drug and Gene Delivery System Revenue and Gross Margin, 2018-2023
Table 31. Johnson & Johnson Recent Developments
Table 32. Novartis Company Information, Head Office, Market Area and Industry Position
Table 33. Novartis Company Profile and Main Business
Table 34. Novartis Drug and Gene Delivery System Models, Specifications and Application
Table 35. Novartis Drug and Gene Delivery System Revenue and Gross Margin, 2018-2023
Table 36. Novartis Recent Developments
Table 37. Roche Company Information, Head Office, Market Area and Industry Position
Table 38. Roche Company Profile and Main Business
Table 39. Roche Drug and Gene Delivery System Models, Specifications and Application
Table 40. Roche Drug and Gene Delivery System Revenue and Gross Margin, 2018-2023
Table 41. Roche Recent Developments
Table 42. Merck & Co. Company Information, Head Office, Market Area and Industry Position
Table 43. Merck & Co. Company Profile and Main Business
Table 44. Merck & Co. Drug and Gene Delivery System Models, Specifications and Application
Table 45. Merck & Co. Drug and Gene Delivery System Revenue and Gross Margin, 2018-2023
Table 46. Merck & Co. Recent Developments
Table 47. Sanofi Company Information, Head Office, Market Area and Industry Position
Table 48. Sanofi Company Profile and Main Business
Table 49. Sanofi Drug and Gene Delivery System Models, Specifications and Application
Table 50. Sanofi Drug and Gene Delivery System Revenue and Gross Margin, 2018-2023
Table 51. Sanofi Recent Developments
Table 52. GlaxoSmithKline Company Information, Head Office, Market Area and Industry Position
Table 53. GlaxoSmithKline Company Profile and Main Business
Table 54. GlaxoSmithKline Drug and Gene Delivery System Models, Specifications and Application
Table 55. GlaxoSmithKline Drug and Gene Delivery System Revenue and Gross Margin, 2018-2023
Table 56. GlaxoSmithKline Recent Developments
Table 57. AbbVie Company Information, Head Office, Market Area and Industry Position
Table 58. AbbVie Company Profile and Main Business
Table 59. AbbVie Drug and Gene Delivery System Models, Specifications and Application
Table 60. AbbVie Drug and Gene Delivery System Revenue and Gross Margin, 2018-2023
Table 61. AbbVie Recent Developments
Table 62. AstraZeneca Company Information, Head Office, Market Area and Industry Position
Table 63. AstraZeneca Company Profile and Main Business
Table 64. AstraZeneca Drug and Gene Delivery System Models, Specifications and Application
Table 65. AstraZeneca Drug and Gene Delivery System Revenue and Gross Margin, 2018-2023
Table 66. AstraZeneca Recent Developments
Table 67. Bayer Company Information, Head Office, Market Area and Industry Position
Table 68. Bayer Company Profile and Main Business
Table 69. Bayer Drug and Gene Delivery System Models, Specifications and Application
Table 70. Bayer Drug and Gene Delivery System Revenue and Gross Margin, 2018-2023
Table 71. Bayer Recent Developments
Table 72. Bristol-MyersSquibb Company Information, Head Office, Market Area and Industry Position
Table 73. Bristol-MyersSquibb Company Profile and Main Business
Table 74. Bristol-MyersSquibb Drug and Gene Delivery System Models, Specifications and Application
Table 75. Bristol-MyersSquibb Drug and Gene Delivery System Revenue and Gross Margin, 2018-2023
Table 76. Bristol-MyersSquibb Recent Developments
Table 77. Celgene Company Information, Head Office, Market Area and Industry Position
Table 78. Celgene Company Profile and Main Business
Table 79. Celgene Drug and Gene Delivery System Models, Specifications and Application
Table 80. Celgene Drug and Gene Delivery System Revenue and Gross Margin, 2018-2023
Table 81. Celgene Recent Developments
Table 82. Amgen Company Information, Head Office, Market Area and Industry Position
Table 83. Amgen Company Profile and Main Business
Table 84. Amgen Drug and Gene Delivery System Models, Specifications and Application
Table 85. Amgen Drug and Gene Delivery System Revenue and Gross Margin, 2018-2023
Table 86. Amgen Recent Developments
Table 87. Biogen Company Information, Head Office, Market Area and Industry Position
Table 88. Biogen Company Profile and Main Business
Table 89. Biogen Drug and Gene Delivery System Models, Specifications and Application
Table 90. Biogen Drug and Gene Delivery System Revenue and Gross Margin, 2018-2023
Table 91. Biogen Recent Developments
Table 92. Gilead Sciences Company Information, Head Office, Market Area and Industry Position
Table 93. Gilead Sciences Company Profile and Main Business
Table 94. Gilead Sciences Drug and Gene Delivery System Models, Specifications and Application
Table 95. Gilead Sciences Drug and Gene Delivery System Revenue and Gross Margin, 2018-2023
Table 96. Gilead Sciences Recent Developments
Table 97. Illumina Company Information, Head Office, Market Area and Industry Position
Table 98. Illumina Company Profile and Main Business
Table 99. Illumina Drug and Gene Delivery System Models, Specifications and Application
Table 100. Illumina Drug and Gene Delivery System Revenue and Gross Margin, 2018-2023
Table 101. Illumina Recent Developments
Table 102. Regeneron Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
Table 103. Regeneron Pharmaceuticals Company Profile and Main Business
Table 104. Regeneron Pharmaceuticals Drug and Gene Delivery System Models, Specifications and Application
Table 105. Regeneron Pharmaceuticals Drug and Gene Delivery System Revenue and Gross Margin, 2018-2023
Table 106. Regeneron Pharmaceuticals Recent Developments
Table 107. Vertex Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
Table 108. Vertex Pharmaceuticals Company Profile and Main Business
Table 109. Vertex Pharmaceuticals Drug and Gene Delivery System Models, Specifications and Application
Table 110. Vertex Pharmaceuticals Drug and Gene Delivery System Revenue and Gross Margin, 2018-2023
Table 111. Vertex Pharmaceuticals Recent Developments
Table 112. Moderna Company Information, Head Office, Market Area and Industry Position
Table 113. Moderna Company Profile and Main Business
Table 114. Moderna Drug and Gene Delivery System Models, Specifications and Application
Table 115. Moderna Drug and Gene Delivery System Revenue and Gross Margin, 2018-2023
Table 116. Moderna Recent Developments
Table 117. CRISPR Therapeutics Company Information, Head Office, Market Area and Industry Position
Table 118. CRISPR Therapeutics Company Profile and Main Business
Table 119. CRISPR Therapeutics Drug and Gene Delivery System Models, Specifications and Application
Table 120. CRISPR Therapeutics Drug and Gene Delivery System Revenue and Gross Margin, 2018-2023
Table 121. CRISPR Therapeutics Recent Developments
List of Figure
Figure 1. Drug and Gene Delivery System Picture
Figure 2. Global Drug and Gene Delivery System Industry Market Size and Forecast (US$ million) & (2018-2029)
Figure 3. China Drug and Gene Delivery System Revenue and Forecast (US$ million) & (2018-2029)
Figure 4. 2018-2029 China Drug and Gene Delivery System Market Share of Global
Figure 5. Global Drug and Gene Delivery System Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 6. Global Drug and Gene Delivery System Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2018-2023
Figure 7. China Drug and Gene Delivery System Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 8. China Drug and Gene Delivery System Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023
Figure 9. Drug and Gene Delivery System Industry Chain
Figure 10. Drug Delivery System
Figure 11. Gene Delivery System
Figure 12. By Type, Global Drug and Gene Delivery System Revenue, 2018-2029, US$ Million
Figure 13. By Type, Global Drug and Gene Delivery System Revenue Market Share, 2018-2029
Figure 14. Diabetes
Figure 15. Central Nervous System
Figure 16. Infectious Disease
Figure 17. Oncology
Figure 18. Other
Figure 19. By Application, Global Drug and Gene Delivery System Revenue, 2018-2029, US$ Million
Figure 20. By Application, Global Drug and Gene Delivery System Revenue Market Share, 2018-2029
Figure 21. By Region, Global Drug and Gene Delivery System Revenue Market Share, 2018-2029
Figure 22. North America Drug and Gene Delivery System Revenue & Forecasts, 2018-2029, US$ Million
Figure 23. By Country, North America Drug and Gene Delivery System Revenue Market Share, 2018-2023
Figure 24. Europe Drug and Gene Delivery System Revenue & Forecasts, 2018-2029, US$ Million
Figure 25. By Country, Europe Drug and Gene Delivery System Revenue Market Share, 2018-2023
Figure 26. Asia Pacific Drug and Gene Delivery System Revenue & Forecasts, 2018-2029, US$ Million
Figure 27. By Country/Region, Asia Pacific Drug and Gene Delivery System Revenue Market Share, 2018-2023
Figure 28. South America Drug and Gene Delivery System Revenue & Forecasts, 2018-2029, US$ Million
Figure 29. By Country, South America Drug and Gene Delivery System Revenue Market Share, 2018-2023
Figure 30. Middle East & Africa Drug and Gene Delivery System Revenue & Forecasts, 2018-2029, US$ Million
Figure 31. U.S. Drug and Gene Delivery System Revenue, 2018-2029, (US$ Million)
Figure 32. By Company, U.S. Drug and Gene Delivery System Market Share, 2018-2023
Figure 33. By Type, U.S. Drug and Gene Delivery System Revenue Market Share, 2022 VS 2029
Figure 34. By Application, U.S. Drug and Gene Delivery System Revenue Market Share, 2022 VS 2029
Figure 35. Europe Drug and Gene Delivery System Revenue, 2018-2029, (US$ Million)
Figure 36. By Company, Europe Drug and Gene Delivery System Market Share, 2018-2023
Figure 37. By Type, Europe Drug and Gene Delivery System Revenue Market Share, 2022 VS 2029
Figure 38. By Application, Europe Drug and Gene Delivery System Revenue Market Share, 2022 VS 2029
Figure 39. China Drug and Gene Delivery System Revenue, 2018-2029, (US$ Million)
Figure 40. By Company, China Drug and Gene Delivery System Market Share, 2018-2023
Figure 41. By Type, China Drug and Gene Delivery System Revenue Market Share, 2022 VS 2029
Figure 42. By Application, China Drug and Gene Delivery System Revenue Market Share, 2022 VS 2029
Figure 43. Japan Drug and Gene Delivery System Revenue, 2018-2029, (US$ Million)
Figure 44. By Company, Japan Drug and Gene Delivery System Market Share, 2018-2023
Figure 45. By Type, Japan Drug and Gene Delivery System Revenue Market Share, 2022 VS 2029
Figure 46. By Application, Japan Drug and Gene Delivery System Revenue Market Share, 2022 VS 2029
Figure 47. South Korea Drug and Gene Delivery System Revenue, 2018-2029, (US$ Million)
Figure 48. By Company, South Korea Drug and Gene Delivery System Market Share, 2018-2023
Figure 49. By Type, South Korea Drug and Gene Delivery System Revenue Market Share, 2022 VS 2029
Figure 50. By Application, South Korea Drug and Gene Delivery System Revenue Market Share, 2022 VS 2029
Figure 51. Southeast Asia Drug and Gene Delivery System Revenue, 2018-2029, (US$ Million)
Figure 52. By Company, Southeast Asia Drug and Gene Delivery System Market Share, 2018-2023
Figure 53. By Type, Southeast Asia Drug and Gene Delivery System Revenue Market Share, 2022 VS 2029
Figure 54. By Application, Southeast Asia Drug and Gene Delivery System Revenue Market Share, 2022 VS 2029
Figure 55. India Drug and Gene Delivery System Revenue, 2018-2029, (US$ Million)
Figure 56. By Company, India Drug and Gene Delivery System Market Share, 2018-2023
Figure 57. By Type, India Drug and Gene Delivery System Revenue Market Share, 2022 VS 2029
Figure 58. By Application, India Drug and Gene Delivery System Revenue Market Share, 2022 VS 2029
Figure 59. Middle East & Asia Drug and Gene Delivery System Revenue, 2018-2029, (US$ Million)
Figure 60. By Company, Middle East & Asia Drug and Gene Delivery System Market Share, 2018-2023
Figure 61. By Type, Middle East & Asia Drug and Gene Delivery System Revenue Market Share, 2022 VS 2029
Figure 62. By Application, Middle East & Asia Drug and Gene Delivery System Revenue Market Share, 2022 VS 2029
Figure 63. Research Methodology
Figure 64. Breakdown of Primary Interviews
Figure 65. Bottom-up Approaches
Figure 66. Top-down Approaches
Research Methodology:
Global Drug and Gene Delivery System Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|